𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Staphylococcus aureus bacteremia in patients receiving pegylated interferon-alpha and ribavirin for chronic hepatitis C virus infection

✍ Scribed by D. Webster; R. Ahmed; P. Tandon; L. Chui; R. R. McDonald; A. Obarianyk; N. Antonishyn; K. Doucette

Book ID
108885981
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
492 KB
Volume
14
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pegylated interferon and ribavirin thera
Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
✍ F. Legrand-Abravanel; F. Nicot; A. Boulestin; K. Sandres-SaunΓ©; J.P. Vinel; L. A πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 91 KB

## Abstract Hepatitis C Virus (HCV) is classified into six genotypes. Genotype 4 is now spreading in Europe, especially among drug users, who are often infected with both HCV and the human immunodeficiency virus (HIV). Previous studies have shown that HCV‐4 responds poorly to interferon. Pegylated

Prevalence and impact of occult hepatiti
Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin
✍ Marion Levast; Sylvie Larrat; Marie-Ange Thelu; Sandrine Nicod; AgnΓ¨s Plages; Al πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 2 views

## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real‐time PCR techniques are available commercially and ca